Head-to-head · WeighScore
BiltRx vs TD Tele-Doc Weight Loss
By GLP-1 ScorecardUpdated
Score comparison
BiltRx has the higher recorded score — 75.3/100 to 61.8/100.
BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.
Before you choose
Before comparing the headline prices, the BiltRx review and the TD Tele-Doc Weight Loss review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, BiltRx vs TeleFirst Med and CoreAge Rx vs TD Tele-Doc Weight Loss compare each of them with another graded program, and the list of alternatives to BiltRx ranks the programs closest to BiltRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | BiltRx | TD Tele-Doc Weight Loss |
|---|---|---|
| WeighScore | 75.3/100 | 61.8/100 |
| Grade | C | C |
| Site position | #59 | #309 |
| Semaglutide | $82/mo advertised medication starting price; confirm care and shipping charges | Starting at $199 (period, and brand or compounded, not stated) |
| Tirzepatide | $130/mo advertised medication starting price; confirm care and shipping charges | Not disclosed |
| Coverage | All 50 states advertised | 2 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes 12-week package totals
- Explains the consultation charge if treatment is declined
What to consider
- Confirm whether consultation and shipping are included in the selected plan
- Renewal cancellation does not refund an approved order
Strengths
- Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
- 100% virtual — weekly appointments with board-certified MDs from home; no travel required
- Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
- In-network with most commercial insurance plans; may cover visits and monitoring equipment
- Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)
What to consider
- No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
- Telehealth available only in Virginia and Maryland; no national reach confirmed
- No Medicare or Medicaid accepted; limited to commercial insurance plans only
- No LegitScript certification found; compounded availability and specific pricing undisclosed on site
- Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.